Clinical Trials · NCT04605861
The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Shanghai Zhongshan Hospital
- Enrollment
- 414
- Start date
- Aug 2020
- Locations
- 1 site, China
- Primary endpoint
- The percentage of body weight loss